Skip to content
Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.
Meijer TG, Nguyen L, Van Hoeck A, Sieuwerts AM, Verkaik NS, Ladan MM, Ruigrok-Ritstier K, van Deurzen CHM, van de Werken HJG, Lips EH, Linn SC, Memari Y, Davies H, Nik-Zainal S, Kanaar R, Martens JWM, Cuppen E, Jager A, van Gent DC.
Oncogene. 2022 Jun 3. doi: 10.1038/s41388-022-02363-1. Epub ahead of print.
Pamiparib for germline BRCA mutation-associated recurrent advanced ovarian, fallopian tube or primary peritoneal cancer.
Skrzypczyk-Ostaszewicz A.
Drugs Today (Barc). 2022 Jun;58(6):299-309. doi: 10.1358/dot.2022.58.6.3389001.
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world.
Pretta A, Spanu D, Mariani S, Liscia N, Ziranu P, Pusceddu V, Puzzoni M, Massa E, Scartozzi M, Lai E.
World J Clin Oncol. 2022 May 24;13(5):417-422. doi: 10.5306/wjco.v13.i5.417.
Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic Defects.
Hasanov E, Pimentel I, Cruellas M, Lewis MA, Jonasch E, Balmaña J.
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-17. doi: 10.1200/EDBK_350232.
Post navigation